Treatment of common enteric parasites.
D000562:Amebiasis / Q000175:diagnosis / Q000188:drug therapy; D000656:Amoeba; D001196:Ascariasis / Q000175:diagnosis / Q000188:drug therapy; D001557:Benzenesulfonates / Q000627:therapeutic use; D001598:Bephenium Compounds / Q000627:therapeutic use; D005243:Feces / Q000382:microbiology; D006725:Hookworm Infections / Q000188:drug therapy; D006801:Humans; D008101:Liver Abscess, Amebic / Q000175:diagnosis; D008795:Metronidazole / Q000627:therapeutic use; D010272:Parasitic Diseases / Q000175:diagnosis / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use; D011715:Pyrantel / Q000627:therapeutic use; D012547:Schistosoma; D012548:Schistosoma haematobium; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000175:diagnosis / Q000188:drug therapy; D012812:Sigmoidoscopy; D013827:Thiabendazole / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D001557:Benzenesulfonates; D001598:Bephenium Compounds; D010879:Piperazines; D008795:Metronidazole; D011715:Pyrantel; D013827:Thiabendazole